1hho: Difference between revisions
New page: left|200px<br /> <applet load="1hho" size="450" color="white" frame="true" align="right" spinBox="true" caption="1hho, resolution 2.1Å" /> '''STRUCTURE OF HUMAN O... |
No edit summary |
||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
The structure of human oxyhaemoglobin was determined by single crystal, X-ray analysis at 2.1 A resolution. Data were collected on an, Arndt-Wonacott camera at -2 degrees C. The structure was refined to an R, factor of 0.223 by the Jack-Levitt method, starting from Baldwin's model, of human carbon monoxide haemoglobin. The active sites in the alpha and, beta subunit are distinct. The iron atoms are 0.16(8) A and 0.00(8) A from, the mean plane of the porphyrin carbons and nitrogens (0.12(8) A and, -0.11(8) A from the mean plane of the porphyrin nitrogens) in the alpha, and beta subunit, respectively, in correlation with the orientation of, HisF8 relative to the porphyrin nitrogens. The haem group appears to be, nearly planar in the alpha subunit but ruffled in the beta subunit. The, Fe-O(1)-O(2) angles are 153(7) degrees and 159(12) degrees in the alpha, and beta subunit, respectively. The oxygen molecule forms a hydrogen bond, to N epsilon of HisE7 in the alpha, but either none or a weak one in the, beta subunit. The following bond lengths were found: Fe-N epsilon (HisF8), = 1.94(9) A (alpha) and 2.07(9) A (beta); Fe-O(1) = 1.66(8) A (alpha) and, 1.87(13) A (beta); Fe-Nporph (mean = 1.99(5) A (alpha) and 1.96(6) A, (beta). These dimensions agree with the values obtained in oxymyoglobin, and model compounds. The C-terminal residues, ArgHC3(141 alpha) and, HisHC3(146 beta), are relatively delocalized, and their positions do not, enable them to form the intersubunit salt bridges in which they are, involved in deoxyhaemoglobin. The penultimate tyrosine residues, TyrHC2, 140 alpha and 145 beta, are relatively localized and maintain the hydrogen, bonds to the carbonyl oxygens of ValFG5 (93 alpha and 98 beta), with only, minor variations compared to their geometry in deoxyhaemoglobin., TyrHC2(145 beta), however, alternates between a major and a minor site, in, conjunction with CysF9(93 beta), both sharing the internal pocket between, the F and H helices while in the major conformation. This suggests that, the role of the penultimate tyrosines in the allosteric mechanism may, differ from that previously proposed by Perutz. The overall quaternary, structure of oxyhaemoglobin is identical, within experimental error, to, that of carbon monoxide haemoglobin, and thus confirms the applicability, of the allosteric mechanisms proposed by Perutz and Baldwin & Chothia to, the process of oxygen binding. | The structure of human oxyhaemoglobin was determined by single crystal, X-ray analysis at 2.1 A resolution. Data were collected on an, Arndt-Wonacott camera at -2 degrees C. The structure was refined to an R, factor of 0.223 by the Jack-Levitt method, starting from Baldwin's model, of human carbon monoxide haemoglobin. The active sites in the alpha and, beta subunit are distinct. The iron atoms are 0.16(8) A and 0.00(8) A from, the mean plane of the porphyrin carbons and nitrogens (0.12(8) A and, -0.11(8) A from the mean plane of the porphyrin nitrogens) in the alpha, and beta subunit, respectively, in correlation with the orientation of, HisF8 relative to the porphyrin nitrogens. The haem group appears to be, nearly planar in the alpha subunit but ruffled in the beta subunit. The, Fe-O(1)-O(2) angles are 153(7) degrees and 159(12) degrees in the alpha, and beta subunit, respectively. The oxygen molecule forms a hydrogen bond, to N epsilon of HisE7 in the alpha, but either none or a weak one in the, beta subunit. The following bond lengths were found: Fe-N epsilon (HisF8), = 1.94(9) A (alpha) and 2.07(9) A (beta); Fe-O(1) = 1.66(8) A (alpha) and, 1.87(13) A (beta); Fe-Nporph (mean = 1.99(5) A (alpha) and 1.96(6) A, (beta). These dimensions agree with the values obtained in oxymyoglobin, and model compounds. The C-terminal residues, ArgHC3(141 alpha) and, HisHC3(146 beta), are relatively delocalized, and their positions do not, enable them to form the intersubunit salt bridges in which they are, involved in deoxyhaemoglobin. The penultimate tyrosine residues, TyrHC2, 140 alpha and 145 beta, are relatively localized and maintain the hydrogen, bonds to the carbonyl oxygens of ValFG5 (93 alpha and 98 beta), with only, minor variations compared to their geometry in deoxyhaemoglobin., TyrHC2(145 beta), however, alternates between a major and a minor site, in, conjunction with CysF9(93 beta), both sharing the internal pocket between, the F and H helices while in the major conformation. This suggests that, the role of the penultimate tyrosines in the allosteric mechanism may, differ from that previously proposed by Perutz. The overall quaternary, structure of oxyhaemoglobin is identical, within experimental error, to, that of carbon monoxide haemoglobin, and thus confirms the applicability, of the allosteric mechanisms proposed by Perutz and Baldwin & Chothia to, the process of oxygen binding. | ||
==Disease== | |||
Known diseases associated with this structure: Erythremias, alpha- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141800 141800]], Erythremias, beta- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Erythrocytosis OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141850 141850]], HPFH, deletion type OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Heinz body anemia OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141850 141850]], Heinz body anemias, alpha- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141800 141800]], Heinz body anemias, beta- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Hemoglobin H disease OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141850 141850]], Hypochromic microcytic anemia OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141850 141850]], Methemoglobinemias, alpha- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141800 141800]], Methemoglobinemias, beta- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Sickle cell anemia OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Thalassemia, alpha- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141850 141850]], Thalassemia-beta, dominant inclusion-body OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Thalassemias, alpha- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141800 141800]], Thalassemias, beta- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]] | |||
==About this Structure== | ==About this Structure== | ||
Line 21: | Line 24: | ||
[[Category: oxygen transport]] | [[Category: oxygen transport]] | ||
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 17:18:11 2007'' |